Jan 11, 2021 / 01:20PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good morning, everyone, and welcome to the JPMorgan Healthcare Conference. My name is Jess Fye. I'm one of the Senior Biotech Analysts at JPMorgan. And we're kicking off the conference for my coverage with Emergent BioSolutions. I'm joined by the company's CEO, Bob Kramer.
And before he gets started, I just want to remind everyone that you can hit the blue "Ask a Question" button, it will send questions to a portal, and then I can ask the management team those questions during the Q&A which will follow the presentation.
So with that, Bob, let me turn it over to you.
Robert G. Kramer - Emergent BioSolutions Inc. - CEO, President & Executive Director
Great. Good morning, everyone. Thank you for joining today's presentation of Emergent BioSolutions. I want to say a special thanks to Jess and her team at JPMorgan for the opportunity to participate again in the conference and for their continued support of our company over the last 15 years.
To
Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers